Research News

UEG Research Prize: € 100,000 for future research on prevention and detection of early GI cancer

Friday, 15 July 2016 14:31

Professor Ernst J. Kuipers has been awarded the distinguished UEG Research Prize 2016 for his outstanding project on “Hidden in plain sight: the opportunities for targeted surveillance and intervention for early gastric neoplasia”. The Prize money will support him and his team in the future research in the field of prevention and detection of early GI cancer. He will receive the Award during the Opening Session on Monday, October 17 at UEG Week Vienna.

Further Infomation

Perianal Crohn's Disease research outcomes

Friday, 15 July 2016 11:06

An exciting new collaborative of UK gastroenterologists and colorectal surgeons is seeking to better understand and study perianal Crohn’s disease. The initiative is being led by Miss Nicola Fearnhead on behalf of ACPGBI and Dr Ailsa Hart on behalf of the BSG. It will involve multiple IBD units across the UK and the initial work has been funded by the Bowel Disease Research Foundation and the BSG.

The collaborative would be extremely grateful for your assistance with developing a Core Outcome Set (COS) for perianal Crohn’s disease. The process consists of three short Delphi consensus surveys via an online platform. In order to register your interest before the deadline of 31 August, please follow the link.

The electronic Delphi exercise will begin later this year; all answers will be kept confidential. A selection across the key stakeholder groups (including patients) will be invited to be participate in a face-to-face consensus exercise following completion of the online rounds. All participants who complete the three online Delphi rounds will be formally acknowledged on any publications.

Further background information is available. Please contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it or This e-mail address is being protected from spambots. You need JavaScript enabled to view it , the trainee leads, for any questions. We welcome your support!

INQUIRE: Improving NHS Quality Using Internet Ratings and Experiences

Friday, 08 July 2016 13:54

INQUIRE is a programme of work funded by the NIHR HS&DR Programme that incorporates five studies about the use of online ratings and reviews of healthcare. As the ubiquity of the internet becomes the accepted method of communicating a person’s thoughts and opinions on their experiences of any particular goods or service, it seems like the right thing for the NHS to do too.

So what are the five parts that make up INQUIRE?:

  • What is already known about feedback from patients?
  • Do people who feedback have certain attitudes and characteristics?
  • Why do people choose to feedback or comment online?
  • How do those on the receiving end feel about the feedback?
  • When feedback is given, does it change what people do and how they do it?

Read Further

Personalised medicine on the move despite Brexit implications

Thursday, 07 July 2016 13:54

The first European Alliance for Personalised Medicine (EAPM) Training and Education for Advanced Clinicians and Healthcare professionals (TEACH) Summer School was held 4-7 July 2016 in Cascais, Portugal. Christine Chomienne, a key player in the event and a past-president of the European Hematology Association, said “With Britain now not too far away from quitting Europe in a legal and practical sense, there are still current and future patients to think about. And their needs must still be met. Training for their doctors and nurses is vital. In fact, it is now more important than ever.”

This report provides an overview of the key outcomes and presentations. The EAPM WG on Education has planned further activities in October and November, 2016.

Given that healthcare is a Member State competence and health services across Europe are already disjointed, collaboration between UK and EU scientists, as well as those experts operating in the field of Big Data, for example, may well become harder. Other areas that could be affected by Brexit include clinical trials, regulation, marketing authorisations, and pharmacovigilance. EAPM’s executive director remained upbeat, saying: “The Alliance will continue to work with its affiliates in the UK, and with those across the remaining Member States.” For further details of European plans, see the full press release from EAPM.

Page 7 of 23